Compensation Analyst

The role

The Compensation Analyst provides analytical expertise and strategic support for compensation structures and programs. This person will manage salary reviews, job classifications, and compensation technology projects to ensure compliance and business alignment.

What you will do

• Support administration and development of compensation structures and policies.
• Review proposed salary increases and provide market and equity analysis.
• Consult on pay recommendations for exempt and non-exempt teammates.
• Partner on development and administration of wages, base salary, bonuses, and incentive structures.
• Evaluate and refine job descriptions and assess FLSA exemption classifications.
• Lead compensation-related technology projects and automation initiatives.
• Ensure compliance with regulatory requirements and oversee compensation reporting and audits.
• Perform annual and ad hoc compensation analyses against market data.
• Prepare reports, dashboards, and career path documents.
• Facilitate salary survey submissions.

Required qualifications

• Bachelor’s degree in HR, Business or related field
• 6-8 years Compensation at a high-growth company(ies) administering broad-based compensation with exempt and non-exempt roles
• 6-8 years Leading and supporting design of compensation architecture including job leveling and developing wage ranges
• Deep knowledge of executive and non-executive compensation programs including equity planning and practices, base salary, variable pay and performance management, job evaluation, data analysis, resear
• Strong analytical skills
• Strong problem-solving aptitude
• Ability to listen and use critical thinking
• Detail-oriented
• Strong customer orientation
• Ability to handle highly sensitive, proprietary and confidential information appropriately

Nice to have

• Life Sciences experience
• International experience (policy and compliance)
• Workday experience

About the company

Iovance Biotherapeutics, Inc. is a global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors.